z-logo
open-access-imgOpen Access
The Value of Topotecan in the Second-Line Treatment of Small-Cell Lung Cancer. Preliminary Report
Author(s) -
Beata Biernacka,
Paweł Krawczyk,
Jarosław Buczkowski,
Anna Siwiec,
Katarzyna Perżyło,
Janusz Milanowski
Publication year - 2010
Publication title -
advances in respiratory medicine
Language(s) - English
Resource type - Journals
eISSN - 2543-6031
pISSN - 2451-4934
DOI - 10.5603/arm.27726
Subject(s) - topotecan , medicine , oncology , performance status , hazard ratio , chemotherapy , lung cancer , regimen , proportional hazards model , disease , chemotherapy regimen , malignancy , confidence interval

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom